Intellectual Property, Patents United States FDA gets serious about biosimilars 5 September 2018 By Suzy Madar Read on
Intellectual Property, Patents, Technology Is the cure in your DNA? – The rise of biopharmaceuticals and pharmacogenomics-led therapy 4 June 2018 By Veg Tran Read on
Intellectual Property, Patents The Trans-Pacific Partnership’s IP provisions: Biologics and biosimilars, copyright and privacy 9 October 2015 By Alex Horne Read on
